ARTICLE
|
doi:10.20944/preprints202007.0527.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Triple Negative Breast Cancer; Cancer Stem Cell; Hypoxia; EGFR; Cisplatin; PDX
Online: 22 July 2020 (11:32:30 CEST)